Solutions For Maximal Throughput of High-capacity Next Generation Sequencing in the Clinical Lab
Kerry Mullaney
Thursday, October 23, 2014
Tweet
Transcript
Embed
Email
Bookmark
<<
<
>
>>
Tweet
Facebook
Email
Chapters
Introduction
Overview
Cancer and Next Generation Sequencing
Evolution of Cancer Genetics
Lung Adenocarcinoma
Cancer Genetics
Approved Drugs Associated with Molecular Biomarkers
Cancer Genetics (cont.)
KEW Group
History of KEW
Realizing Our Mission
KEW Group’s Oncology Network
Therapeutic Pathways (TPx)
CancerPlex℠
CancerPlex Workflow
Clinical Laboratory
Automation
Automation History
Automation Setup
Why This System?
Versatility - Robot Methods
Adaptability – Robot Hardware
Creating Robotic Methods
Method Writing
Versatility Breeds Complexity
Method Decisions
User Interface
User Friendly
Deck Design
Clinical Benefits
User Errors
Troubleshooting
Maintenance
Timeline Expectations
Optimization
Method Optimization – Lessons Learned
Method Optimization – Examples
Robotic Validation Study
Pipeline Information
Coverage Profile
Translocation Detection
Validating the Robotic Assay - Example Metrics
Clinical Production Considerations
Conclusions
KEW’s Impact
References
No transcript for this webinar
More Information
Request info